SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-506937
Filing Date
2016-03-16
Accepted
2016-03-16 17:22:33
Documents
4
Period of Report
2016-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d147708d8k.htm 8-K 24313
2 EX-10.1 d147708dex101.htm EX-10.1 82304
3 EX-10.2 d147708dex102.htm EX-10.2 82170
4 GRAPHIC g147708logo.jpg GRAPHIC 20167
  Complete submission text file 0001193125-16-506937.txt   218050
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 161510556
SIC: 2834 Pharmaceutical Preparations